Utilization of the Bologna criteria: a promise unfulfilled? A review of published and unpublished/ongoing trials

Fertil Steril. 2018 Jan;109(1):104-109.e2. doi: 10.1016/j.fertnstert.2017.09.024. Epub 2017 Nov 29.

Abstract

Objective: To study the use of the Bologna criteria (BC) for the definition of poor ovarian responders (POR) in clinical practice and research.

Design: Systematic review of published and unpublished/ongoing trials between January 2012 and August 2017 on POR.

Setting: Not applicable.

Patient(s): Not applicable.

Intervention(s): The databases were searched using the relevant medical subject headings including all subheadings. The search was limited to humans and English language. The references of the included studies were cross-searched for possibly missed articles. Only clinical trials providing an evidence level ≥ III were included. Case reports, review, letters, and hypothetical articles were excluded.

Main outcome measure(s): Extracted studies were divided into two groups: studies in which the BC were used or not.

Result(s): One hundred nine published clinical studies analyzing a total of 30,540 women and 112 unpublished/ongoing trials were identified. The BC were used to define POR in 56 (51%) of the published and 44 (39%) of the unpublished trials. The use of the BC gradually increased from 29% to 53% from 2012 to 2017. Asian researchers were more likely to use the BC compared with European and North American researchers (65%, 49%, and 23%, respectively). Neither the design of the study nor the impact factor of the publishing journal was correlated with the use of the BC.

Conclusion(s): There is still reluctance to use the BC for the definition of POR, which makes it difficult to combine data from small studies and reach a meaningful conclusion.

Keywords: Bologna criteria; Poor ovarian response; definition.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Decision Support Techniques*
  • Evidence-Based Medicine
  • Female
  • Fertility Agents / administration & dosage*
  • Fertility Agents / adverse effects
  • Humans
  • Infertility, Female / diagnosis
  • Infertility, Female / physiopathology
  • Infertility, Female / therapy*
  • Ovary / drug effects*
  • Ovary / physiopathology
  • Ovulation / drug effects*
  • Ovulation Induction / adverse effects
  • Ovulation Induction / methods*
  • Predictive Value of Tests
  • Pregnancy
  • Risk Factors
  • Terminology as Topic
  • Treatment Outcome

Substances

  • Fertility Agents